In an interview on CNBC’s Mad Money, Marc Casper said 2023 was a reset year for Thermo Fisher, and 2024 will be a recovery year. He expects the company to exit 2024 at its normal growth rate. It has transferred its Covid-related capacity to GLP-1’s, so there is potential for tremendous growth there, he noted. He expects modest growth in China this year and is positive on it long term.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TMO:
